Detalhe da pesquisa
1.
Chronic viral coinfections differentially affect the likelihood of developing long COVID.
J Clin Invest
; 133(3)2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36454631
2.
Impact of Pre-Existing Chronic Viral Infection and Reactivation on the Development of Long COVID.
medRxiv
; 2022 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35898346
3.
First-in-human immunoPET imaging of HIV-1 infection using 89Zr-labeled VRC01 broadly neutralizing antibody.
Nat Commun
; 13(1): 1219, 2022 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35264559
4.
Discordant Virus-Specific Antibody Levels, Antibody Neutralization Capacity, and T-cell Responses Following 3 Doses of SARS-CoV-2 Vaccination in a Patient With Connective Tissue Disease.
Open Forum Infect Dis
; 8(8): ofab393, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34395717
5.
Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations.
Cells
; 10(2)2021 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33668514
6.
Genome-wide DNA methylation profiling of peripheral blood reveals an epigenetic signature associated with severe COVID-19.
J Leukoc Biol
; 110(1): 21-26, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33464637
7.
Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection.
Nat Biotechnol
; 39(8): 928-935, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33767397
8.
Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms.
Cell Rep
; 36(6): 109518, 2021 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34358460
9.
Long-Term SARS-CoV-2-Specific Immune and Inflammatory Responses Across a Clinically Diverse Cohort of Individuals Recovering from COVID-19.
medRxiv
; 2021 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33688685
10.
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay.
Sci Adv
; 7(31)2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34330709
11.
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay.
medRxiv
; 2021 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33688675